CHO PHARMA (TPE: 6586) will hold an online investors’ conference on September 13 at 16:00 (Taipei Time) to disclose Phase I clinical results of CHO-H01, update pipeline development, announce current financial plans, and reveal future operation advancement and strategies.
The link to CHO PHARMA Investors’ Conference:
https://masterlinkc001.webex.com/masterlinkc001-tc/j.php?MTID=m0d0118bed9c6210a43f628963a9ee241
Meeting Number: 2510 013 1514
Meeting Password: 6586